ALNYLAM PHARMACEUT earnings per share and revenue

DUL earnings per share for the last quarter are -0.47 CHF whereas the estimation was -1.01 CHF which accounts for 53.41% surprise. Företagets omsättning för samma period uppgår till 445.95 M CHF trots den uppskattade siffran 386.11 M CHF. Estimated earnings per share for the next quarter are -0.95 CHF, and revenue is expected to reach 403.07 M CHF. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.